Mico Biomed Co. Ltd. logo

Mico Biomed Co. Ltd. (214610)

Market Closed
26 Jun, 06:30
KRX SM KRX SM
2,290. 00
0
0%
19.29B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
2,290
Previous Close
Add Transaction
Day Range
2,290 2,290
Year Range
2,255 8,470
Want to track 214610 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

214610 closed Friday higher at ₩2,290, an increase of 0% from Thursday's close, completing a monthly decrease of -13.5849% or -₩360. Over the past 12 months, 214610 stock lost -36.7403%.
214610 is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Mico Biomed Co. Ltd. has completed 2 stock splits, with the recent split occurring on Apr 14, 2025.
The company's stock is traded on one exchange.

214610 Chart

People also search for

I-Scream Media Co. Ltd.
18,230
-1.0852%
Cube Entertainment Inc.
6,210
+2.6446%
LG Hellovision Co., Ltd.
1,756
+2.1524%
Showbox Corp.
2,075
+3.75%
Aniplus Inc.
2,810
+1.6275%

Mico Biomed Co. Ltd. (214610) FAQ

What is the stock price today?

The current price is ₩2,290.00.

On which exchange is it traded?

Mico Biomed Co. Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 214610.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 19.29B.

Has Mico Biomed Co. Ltd. ever had a stock split?

Mico Biomed Co. Ltd. had 2 splits and the recent split was on Apr 14, 2025.

Mico Biomed Co. Ltd. Profile

Media Industry
Communication Services Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
48 Employees
- Last Dividend
14 Apr 2025 Last Split
- IPO Date

Overview

MiCo BioMed Co., Ltd., formerly known as MiCo NanoBioSys Co., Ltd. until March 2018, stands at the forefront of on-site diagnostic technology through its innovative Lab-on-a-Chip systems. Established in 2009, the company is headquartered in Seongnam-si, South Korea. It specializes in the development and manufacturing of molecular diagnostics devices, biological chemistry products, and immunodiagnostics products, catering to the need for rapid and reliable diagnostic solutions across the healthcare industry.

Products and Services

  • Veri-Q PREP M16 (G2-16TU) System - A revolutionary device that utilizes a membrane in a tube format for efficient nucleic acid extraction. This system is designed to streamline the sample preparation process, facilitating quicker diagnostic assessments.
  • VERI-Q PCR 316 - A cutting-edge device employing plastic chip technology to deliver rapid PCR (Polymerase Chain Reaction) results. This system is tailored for settings requiring swift turn-around times without compromising accuracy.
  • VERI-Q PCR 204 (G2-4) - This device offers a real-time PCR system in a compact form factor, enabling precise and timely diagnostics in various clinical settings.
  • PCR and Sample Prep Kits - Complementary to MiCo BioMed’s PCR systems, these kits provide the necessary reagents and tools for effective sample preparation and PCR analysis, ensuring consistency and reliability in results.
  • LabChip, Sample Tube, and Pre-Filtering Column - Accessories and consumables designed to support and optimize the performance of MiCo BioMed’s systems, ensuring efficient sample processing and accurate diagnostic outcomes.
  • VERI-Q Multi - A cholesterol diagnostic product that combines convenience with accuracy, catering to the growing need for on-site cholesterol monitoring.
  • VERI-Q Hb Mate and VERI-Q RED - Hemoglobin monitoring systems that simplify the process of tracking hemoglobin levels, facilitating effective management of conditions such as anemia.
  • VERI-Q PRO - A blood glucose monitoring system that offers fast, reliable results, supporting individuals in their management of diabetes.
  • VERI-Q COVID-19 Ag Rapid Test and VERI-Q COVID-19 IgGIgM Rapid Test - These tests provide quick and accurate detection of COVID-19 antigens and antibodies, respectively, playing a crucial role in the pandemic response efforts.
  • VERI-Q PinoView - A diagnostic tool designed for the detection of specific disease markers through antigen-antibody reaction, offering a versatile platform for various immunodiagnostics applications.
  • Opti96 ELISA plate/Kit - A comprehensive solution for ELISA (Enzyme-Linked Immunosorbent Assay) testing, facilitating accurate detection and quantification of antigens or antibodies in samples.

Contact Information

Address: 54 Changeop-ro
Phone: 82 1 661 6555